|
FY2025
9 months to Sep 30, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of goods sold | |||||
| Gross profit (loss) | |||||
| Other income | |||||
| Fair value unrealized gain of unlisted financial assets | |||||
| Selling and distribution expenses | |||||
| Administrative expenses | |||||
| Bad debt reversal (expense) | |||||
| Bad debt reversal | |||||
| Finance costs | |||||
| Other expenses | |||||
| Loss before taxation | |||||
| Income tax expense | |||||
| Net loss for the period/year from continuing operations | |||||
| Discontinued operations | |||||
| Gain on disposal of discontinued operations | |||||
| Loss from discontinued operations | |||||
| Net loss | |||||
| Net loss attributable to: | |||||
| Equity holders of the Company | |||||
| Non-controlling interest | |||||
| Net loss attributable to the equity holders of the Company arising from: | |||||
| Continuing operations | |||||
| Discontinued operations | |||||
| Other comprehensive loss | |||||
| Exchange differences on translation of financial statements of foreign operations | |||||
| Exchange differences on translation of financial statements of foreign operations - non-controlling interest | |||||
| Total comprehensive loss | |||||
| Total comprehensive loss attributable to: | |||||
| Equity holders of the Company | |||||
| Non-controlling interest | |||||
| Total comprehensive (loss) income arising from: | |||||
| Continuing operations | |||||
| Discontinued operations | |||||
| Weighted average number of ordinary shares outstanding used in computing basic loss per share | |||||
| Weighted average number of ordinary shares outstanding used in computing diluted loss per share | |||||
| — from continuing operations | |||||
| — from discontinued operations | |||||
Loading...